Racial & Ethnic minority Acceleration Consortium for Health Equity (REACH) Response from Indigenous Innovators Collaborative

种族

• 批准号: 10823600
• 负责人: Billie Kipp
• 金额: $ 50万
• 依托单位: AMERICANS FOR INDIAN OPPORTUNITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-06-05 至 2025-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10823600
• 关键词: Racial; Ethnic; minority; Acceleration; Consortium

Project Summary/Abstract 30 lines of text With a collaborative approach grounded in Indigenous core cultural values, the Indigenous Innovators Collaborative (IIC) team will engage in community-based participatory research study to address the FDA priorities as outlined in FDA OMHHE Health Equity Innovation Award: Racial and Ethnic Minority Acceleration Consortium for Health Equity (REACH) funding opportunity. The IIC seeks to engage American Indian and Alaska Native (AIAN) communities, stakeholders, researchers in an exploration of clinical trials and promote cultural knowledge in understanding clinical trials in Indian Country. The IIC consists of core partners that form the Administrative Core (AC) of this project, including: (1) Americans for Indian Opportunity (AIO), which serves as the fiscal agent/grant administrator; (2) Co-Investigator 1: Dr. Myra Parker (Three Affiliated Tribes), University of Washington; (3) Co-Investigator 2: Dr. Billie Jo Kipp (Blackfeet), Natives in Philanthropy; (4) Principle Investigator: Stephine Poston (Pueblo of Sandia), Poston & Associates, LLC; and, (5) the United Tribes Technical College (UTTC), an accredited, land-grant tribal college located in Bismarck, North Dakota, that serves the five reservations in ND and tribal members across the U.S. UTTC has provided higher education support to over 10,000 AI students from over 75 tribes. We propose to expand this effort to implement an exploratory study that would employ a mixed methods approach to improve understandings of AIAN perceptions of clinical trials and gene therapy across multiple regions of the U.S. Our aims include: 1. Specific Aim 1 – Partner with local tribal colleges to assess AIAN community knowledge, concerns, and beliefs about clinical trials and gene therapy within the 12 IHS regions using a mixed methods approach. a. Hypothesis 1 – AIAN community knowledge, concerns, and beliefs about clinical trials and gene therapy will vary across IHS regions and will reflect local tribal cultural understandings. 2. Specific Aim 2 – Identify barriers and supports for clinical trials and gene therapy among AIAN within the 12 IHS regions by collecting qualitative data from AIAN providers, researchers, and public health experts. a. Hypothesis 2 – Barriers and supports for clinical trials and gene therapy among AIAN will vary by IHS Region and tribal cultures.

项目摘要/摘要30行文本行 以土著核心文化价值为基础的协作方法，土著 创新者协作（IIC）团队将参与基于社区的参与研究 旨在解决FDA优先事项的研究，如FDA Omhhe健康公平创新奖： 种族和族裔少数民族加速联盟的健康平等（覆盖范围）资金 机会。 IIC试图与美洲印第安人和阿拉斯加人（Aian）社区互动， 利益相关者，研究人员探索临床试验并促进文化知识 了解印度国家的临床试验。 IIC由组成的核心合作伙伴组成 该项目的行政核心（AC），包括：（1）美国人寻求印度机会（AIO）， 作为财政代理/赠款管理员； （2）共同评论者1：Myra Parker博士 （三个附属部落），华盛顿大学； （3）共同研究员2：Billie Jo Kipp博士 （Blackfeet），慈善事业的当地人； （4）主要调查员：Stephen Poston（Pueblo Sandia），Poston＆Associates，LLC； （5）联合部落技术学院（UTTC）， 位于北达科他州Bismarck的认可的土地授予部落学院，该学院为五个 美国UTTC的ND和部落成员的预订已提供高等教育 支持来自75个部落的10,000多名AI学生。我们建议将这项工作扩展到 实施一项探索性研究，该研究将采用混合方法来改进 对Aian对临床试验和基因疗法的看法的理解 美国我们的目标包括： 1。特定目的1 - 与当地部落学院的合作，以评估AIAN社区 知识，关注和相信12 IHS中的临床试验和基因疗法 使用混合方法方法的区域。 一个。假设1 - 艾安社区知识，关注和相信临床 试验和基因疗法在IHS地区将有所不同，并将反映当地部落 文化理解。 2。具体目标2 - 确定临床试验和基因治疗的障碍和支持 通过从Aian收集定性数据，在12个IHS区域内的AIAN中 提供者，研究人员和公共卫生专家。 一个。假设2 - 临床试验和基因治疗的障碍和支持 艾安（Aian）将因IHS地区和部落文化而异。